Related Experiment Video
Updated: May 3, 2026
07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.3K
Mutational profiling in melanocytic tumors: multiple somatic mutations and clinical implications
Antonio Giovanni Richetta1, Valentina Silvestri, Simona Giancristoforo
1Unit of Dermatology, Department of Internal Medicine and Medical Specialties, 'Sapienza' University of Rome, Rome, Italy.
Oncology
|January 25, 2014
Summary
Melanoma tumors frequently exhibit multiple gene mutations. Assessing these mutations, including CDKN2A, can offer a genetic profile for prognosis and targeted therapy in melanocytic tumors.
Area of Science:
- Oncology
- Genetics
- Dermatology
Background:
- Melanoma tumorigenesis involves complex genetic alterations.
- Targeted therapies require understanding specific gene mutations.
Purpose of the Study:
- To analyze somatic mutations in 10 key genes in melanoma.
- To evaluate the potential of mutation profiles as prognostic and therapeutic markers.
Main Methods:
- Analysis of somatic mutations across 10 melanoma-relevant genes.
- Assessment of mutation frequency and co-occurrence in tumor samples.
Main Results:
- 45% of melanoma tumors analyzed had detectable mutations.
- 33% of tumors displayed multiple mutations in the studied genes.
- Specific gene mutation patterns were identified.
Conclusions:
- Multiple gene mutations are common in melanoma.
- Assessing mutation status, including CDKN2A, provides a valuable genetic profile.
- This genetic profile can serve as a prognostic and therapeutic marker for melanocytic tumors.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K